Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Fabrice Andre"'
Autor:
Shawn M. Sweeney, Gerrit A. Meijer, Michele L. LeNoue-Newton, Christine M. Micheel, Philippe L. Bedard, Victor E. Velculescu, Charles L. Sawyers, Nikolaus Schultz, Mia A. Levy, Justin Guinney, Fabrice Andre, Barrett J. Rollins, Kenna R. Mills Shaw
Publikováno v:
JCO Clinical Cancer Informatics
The American Association for Cancer Research (AACR) Project Genomics Evidence Neoplasia Information Exchange (GENIE) is an international data-sharing consortium focused on enabling advances in precision oncology through the gathering and sharing of t
Autor:
Guido Kroemer, Jonathan M. Pitt, Laurence Zitvogel, Fabrice Andre, Sebastian Amigorena, Alexander M.M. Eggermont, Jean-Charles Soria
Publikováno v:
Journal of Clinical Investigation
Journal of Clinical Investigation, American Society for Clinical Investigation, 2016, 126 (4), pp.1224-1232. ⟨10.1172/JCI81137⟩
Journal of Clinical Investigation, 2016, 126 (4), pp.1224-1232. ⟨10.1172/JCI81137⟩
Journal of Clinical Investigation, American Society for Clinical Investigation, 2016, 126 (4), pp.1224-1232. 〈10.1172/JCI81137〉
Journal of Clinical Investigation, American Society for Clinical Investigation, 2016, 126 (4), pp.1224-1232. ⟨10.1172/JCI81137⟩
Journal of Clinical Investigation, 2016, 126 (4), pp.1224-1232. ⟨10.1172/JCI81137⟩
Journal of Clinical Investigation, American Society for Clinical Investigation, 2016, 126 (4), pp.1224-1232. 〈10.1172/JCI81137〉
International audience; DC-derived exosomes (Dex) are nanometer-sized membrane vesicles that are secreted by the sentinel antigen-presenting cells of the immune system: DCs. Like DCs, the molecular composition of Dex includes surface expression of fu
Autor:
Geneviève Boileau-Jolimoy, Anne-Laure Martin, Thierry Petit, Patrick Arveux, Elisé G. Kaboré, Paul Cottu, Johanna Wassermann, A. Lesur, Florence Dalenc, Ines Vaz-Luis, Charles Guenancia, Mahmoud Ibrahim, Olivier Arsene, Fabrice Andre, Jérôme Lemonnier, Barbara Pistilli, Charles Coutant, Antonio Di Meglio, Antoine Arnaud, Philippe Rouanet
Publikováno v:
PLoS Medicine
PLoS Medicine, Public Library of Science, 2019, 16 (12), pp.e1002989. ⟨10.1371/journal.pmed.1002989⟩
PLoS Medicine, 2019, 16 (12), pp.e1002989. ⟨10.1371/journal.pmed.1002989⟩
PLoS Medicine, Vol 16, Iss 12, p e1002989 (2019)
PLoS Medicine, Public Library of Science, 2019, 16 (12), pp.e1002989. ⟨10.1371/journal.pmed.1002989⟩
PLoS Medicine, 2019, 16 (12), pp.e1002989. ⟨10.1371/journal.pmed.1002989⟩
PLoS Medicine, Vol 16, Iss 12, p e1002989 (2019)
Background In patients treated with cardiotoxic chemotherapies, the presence of cardiovascular risk factors and previous cardiac disease have been strongly correlated to the onset of cardiotoxicity. The influence of overweight and obesity as risk fac
Autor:
Véronique Scott, Thomas Bachelot, Celine Lefebvre, Séverine Guiu, Jean-Marc Ferrerro, Yannick Boursin, Jean-Charles Soria, Ludovic Lacroix, Marc Deloger, Anthony Gonçalves, Maud Kamal, Fabrice Andre, Fanny Le Du, Florence Dalenc, Christophe Massard, Gilles Romieu, Yu Fu, Christophe Le Tourneau, Thomas Filleron, Marta Jimenez, Hervé Bonnefoi, Magali Lacroix-Triki, Maria Vittoria Dieci, Marion Pedrero, Julie Garrabey, J C Théry, Laurence Vanlemmens, Marie-Ange Mouret Reynier, Christelle Levy, Véronique Diéras, Monica Arnedos, Mario Campone, Gilles Clapisson, Frédéric Commo
Publikováno v:
PLoS Medicine
PLoS Medicine, 2016, 13 (12), pp.e1002201. ⟨10.1371/journal.pmed.1002201⟩
PLoS Medicine, Public Library of Science, 2016, 13 (12), pp.e1002201. ⟨10.1371/journal.pmed.1002201⟩
PLoS Medicine, Vol 13, Iss 12, p e1002201 (2016)
PLoS Medicine, 2016, 13 (12), pp.e1002201. ⟨10.1371/journal.pmed.1002201⟩
PLoS Medicine, Public Library of Science, 2016, 13 (12), pp.e1002201. ⟨10.1371/journal.pmed.1002201⟩
PLoS Medicine, Vol 13, Iss 12, p e1002201 (2016)
Background Major advances have been achieved in the characterization of early breast cancer (eBC) genomic profiles. Metastatic breast cancer (mBC) is associated with poor outcomes, yet limited information is available on the genomic profile of this d
Autor:
Charles Coutant, Roman Rouzier, Frédérique Penault-Lorca, Marc Debled, David Azria, Bernard Asselain, Etienne Brain, Anne Tardivon, Thomas Bachelot, Patrick Arveux, Marc Espié, Anne-Claire Hardy-Bessard, Christelle Levy, William Jacot, Jérôme Lemonnier, Joseph Gligorov, David G. Cox, Corinne Balleyguier, Fabrice Andre, Jean-Philippe Jacquin, Hugues Bourgeois, Mario Campone, François-Clément Bidard, Anthony Gonçalves, Hervé Bonnefoi, Bruno Coudert, Florence Dalenc, J. Grenier, Johanna Arvis, Martine Castro, Thierry Petit, Gérard Ganem, Suzette Delaloge, Alain Lortholary, Laurence Venat-Bouvet
Publikováno v:
Bulletin du Cancer
Bulletin du Cancer, John Libbey Eurotext, 2016, 103 (9), pp.753-763. ⟨10.1016/j.bulcan.2016.06.005⟩
Bulletin du Cancer, 2016, 103 (9), pp.753-763. ⟨10.1016/j.bulcan.2016.06.005⟩
Bulletin du Cancer, John Libbey Eurotext, 2016, 103 (9), pp.753-763. ⟨10.1016/j.bulcan.2016.06.005⟩
Bulletin du Cancer, 2016, 103 (9), pp.753-763. ⟨10.1016/j.bulcan.2016.06.005⟩
Breast cancer remains a potentially lethal disease, which requires aggressive treatments and is associated with long-term consequences. Its prognosis is linked to both tumor biology and burden at diagnosis. Although treatments have allowed important
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5aeb6d22885ecded4d0b4e08913c4512
https://www.hal.inserm.fr/inserm-01822723/file/1-s2.0-S0007455116301047-main.pdf
https://www.hal.inserm.fr/inserm-01822723/file/1-s2.0-S0007455116301047-main.pdf
Autor:
Elsa Vanhecke, Jean Pierre Pignon, Ariane Dunant, Patrick Saulnier, Nicolas Dorvault, Vanessa Rousseau, Stephen L. Graziano, Fabrice Andre, Annabelle Stoclin, Angélique Robin, Lesley Seymour, Frédéric Commo, Eric Solary, Jürgen Thomale, Frances A. Shepherd, Robert A. Kratzke, Julien Adam, Gwénaël Le Teuff, Florence Ponsonnailles, Ken A. Olaussen, Robert Pirker, Jean-Charles Soria, Martin Filipits, Elisabeth Brambilla, Jean-Yves Douillard, Ming-Sound Tsao, Thierry Le Chevalier, Luc Friboulet
Publikováno v:
New England Journal of Medicine
The excision repair cross-complementation group 1 (ERCC1) protein is a potential prognostic biomarker of the efficacy of cisplatin-based chemotherapy in non-small-cell lung cancer (NSCLC). Although several ongoing trials are evaluating the level of e
Autor:
Aicha Goubar, Julien Adam, Joanna Cyrta, Kariman Chaba, Mireia Niso-Santano, Valentina La Sorsa, Laurence Zitvogel, Christina Pfirschke, Guido Kroemer, Gilles Uzé, Oliver Kepp, Magali Lacroix-Triki, Francesca Urbani, Antonella Sistigu, Elisa E. Baracco, Suzette Delaloge, Sylvain Ladoire, David Enot, Camilla Engblom, Marco Bianchi, Laurent Arnould, Virginie Quidville, Mauro Delorenzi, Enrico Proietti, Melvyn T. Chow, Laetitia Aymeric, Fabrice Andre, Giovanna Ziccheddu, Joachim L. Schultze, Alexander M.M. Eggermont, Thomas Tüting, Laetitia Fend, Mark J. Smyth, Catarina Remédios, Takahiro Yamazaki, Robert D. Schreiber, Laura Bracci, Erika Vacchelli, Rosa Conforti, Ilio Vitale, Paola Sestili, Mikael J. Pittet, Marie Charlotte Dessoliers, Filippo Belardelli, Vichnou Poirier-Colame, Frédérique Penault-Llorca, Jean Philippe Spano, Lajos Pusztai, Xavier Préville, Dalil Hannani, Yuting Ma
Publikováno v:
Nature Medicine
Nature Medicine, 2014, 20 (11), pp.1301-1309. ⟨10.1038/nm.3708⟩
Nature Medicine, Nature Publishing Group, 2014, 20 (11), pp.1301-1309. ⟨10.1038/nm.3708⟩
Nature Medicine, 2014, 20 (11), pp.1301-1309. ⟨10.1038/nm.3708⟩
Nature Medicine, Nature Publishing Group, 2014, 20 (11), pp.1301-1309. ⟨10.1038/nm.3708⟩
International audience; The immune system is routinely confronted with cell death resulting from the physiological turnover of renewable tissues, as well as from pathological insults of several types. We hypothesize the existence of a mechanism that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82da2ac4f24fe2532be1b2a721155aa1
https://hal.science/hal-02047408
https://hal.science/hal-02047408
Autor:
Laurie Menger, Lorenzo Galluzzi, Xavier Gidrol, Mickaël Michaud, Erika Vacchelli, Grégoire Mignot, Yuting Ma, Eric Sulpice, François Ghiringhelli, Nazanine Modjtahedi, Fabrice Andre, Frédéric Schlemmer, Clara Locher, Guido Kroemer, Takahiro Yamazaki, Oliver Kepp, Isabelle Martins, Sandy Adjemian, Laurence Zitvogel, Shensi Shen, Abdul Qader Sukkurwala
Publikováno v:
Science Translational Medicine
Science Translational Medicine, American Association for the Advancement of Science, 2012, 4 (143), pp.143ra99-143ra99. ⟨10.1126/scitranslmed.3003807⟩
Science Translational Medicine, American Association for the Advancement of Science (AAAS), 2012, 4 (143), pp.143ra99-143ra99. ⟨10.1126/scitranslmed.3003807⟩
Science Translational Medicine, 2012, 4 (143), pp.143ra99-143ra99. ⟨10.1126/scitranslmed.3003807⟩
Science Translational Medicine, American Association for the Advancement of Science, 2012, 4 (143), pp.143ra99-143ra99. ⟨10.1126/scitranslmed.3003807⟩
Science Translational Medicine, American Association for the Advancement of Science (AAAS), 2012, 4 (143), pp.143ra99-143ra99. ⟨10.1126/scitranslmed.3003807⟩
Science Translational Medicine, 2012, 4 (143), pp.143ra99-143ra99. ⟨10.1126/scitranslmed.3003807⟩
Some successful chemotherapeutics, notably anthracyclines and oxaliplatin, induce a type of cell stress and death that is immunogenic, hence converting the patient's dying cancer cells into a vaccine that stimulates antitumor immune responses. By mea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddc2c06705d53a3270a37d071258492b
https://hal.archives-ouvertes.fr/hal-02356568
https://hal.archives-ouvertes.fr/hal-02356568
Autor:
Lionel Apetoh, Karim Vermaelen, Ahmet Civas, Laetitia Aymeric, Antoine Tesniere, Jean-Luc Perfettini, Jürg Tschopp, Mark J. Smyth, Theocharis Panaretakis, Grégoire Mignot, Fabrice Andre, Evelyn Ullrich, Yuting Ma, Martin Uhl, François Ghiringhelli, Nicole M. Haynes, Bernhard Ryffel, Carla Ortiz, Laurence Zitvogel, Ezgi Tasdemir, Nicole McLaughlin, Rosette Lidereau, Jean Kanellopoulos, Pierre Génin, Guido Kroemer, Frédéric Schlemmer
Publikováno v:
Nature Medicine
Nature Medicine, Nature Publishing Group, 2009, epub ahead of print. ⟨10.1038/nm.2028⟩
Nature Medicine, Nature Publishing Group, 2009, epub ahead of print. ⟨10.1038/nm.2028⟩
International audience; The therapeutic efficacy of anticancer chemotherapies may depend on dendritic cells (DCs), which present antigens from dying cancer cells to prime tumor-specific interferon-gamma (IFN-gamma)-producing T lymphocytes. Here we sh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62669f199a467ff9c78cb8c38bf14057
https://hal.archives-ouvertes.fr/hal-00419823
https://hal.archives-ouvertes.fr/hal-00419823
Autor:
Guido Kroemer, Antoine Tesniere, François Ghiringhelli, Fabrice Andre, Lionel Apetoh, Laurence Zitvogel
Publikováno v:
Journal of Clinical Investigation; Vol 118
Although the impact of tumor immunology on the clinical management of most cancers is still negligible, there is increasing evidence that anticancer immune responses may contribute to the control of cancer after conventional chemotherapy. Thus, radio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63c176753457c9fbbc3094cc15ce1f0f
https://europepmc.org/articles/PMC2396905/
https://europepmc.org/articles/PMC2396905/